ACTHREL

This brand name is authorized in United States. It is also authorized in UK.

Active ingredients

The drug ACTHREL contains one active pharmaceutical ingredient (API):

1	Corticorelin UNII 56X54T817Q - CORTICORELIN OVINE TRIFLUTATE
	Corticorelin results in a rapid and sustained increase of plasma ACTH levels and a near parallel increase of plasma cortisol. In addition corticorelin causes a concomitant and prolonged release of the related proopiomelanocortin peptides β- and γ-lipotropins (β- and γ-LPH) and β-endorphin (β-END).
	Read more about Corticorelin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ACTHREL Powder for solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01AA01	Corticotropin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AA ACTH
Discover more medicines within H01AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	326208
US	FDA, National Drug Code	55566-0302